2nd Annual Dry-AMD Therapeutic Development Summit

Memo

Welcome to the 2nd Annual Dry AMD Therapeutic Development Summit: Uncovering the Largest Untapped Eyecare Market and Enhancing Ocular Research to Bring About Clinically Effective Therapies for Dry-AMD and GA. Returning for its 2nd year as the world’s leading industry forum, Dry-AMD Therapeutic Development establishes meaningful clinical endpoints using the latest diagnostic imaging techniques to prove therapeutic safety and efficacy in specific patient populations. In the context of unprecedented Phase III progress, and as new investigational pharmacological agents enter the clinic, Dry-AMD Therapeutic Development will deliver a greater breadth and depth of technical content than any other meeting in this field with 3 days and 2 tracks of dedicated content. Uniting large pharma, biotech and academic KOLs with a reimagined agenda, this year’s meeting devotes specific content to the unique discovery, pre-clinical, translational, clinical development and commercialization challenges encountered within the dry-AMD space. Ensuring that whatever your role in the field, you will leave with tangible actions to implement into your strategy and pipeline, to translate the promise of dry AMD therapies into a reality for patients. Join the 200+ expert community, as they unite under a common goal of accelerating the approval of next generation therapies for this progressive eye disease. Hear updates from latest clinical programs, strive to identify novel therapeutic targets, learn from recent clinical failures, and evaluate several promising drugs for different stages of dry-AMD. As the only forum solely dedicated to identifying future portfolio strategies to develop interventions to slow and/or reverse the progression of various stages of dry-AMD and geographic atrophy, there has never been a more important time to attend Dry-AMD Therapeutic Development Summit. Date and Time: On Tuesday October 19, 2021 at 9:30 am (ends Thursday October 21, 2021 at 6:00 pm) Prices: Drug Developer Pricing - Conference Only: USD 1599.00,Drug Developer Pricing - Conference + Focus Day: USD 1997.00,Drug Developer Pricing - Conference + 2 Workshops: USD 1997.00,Drug Developer Pricing - Conference + 1 Workshop: USD 1798.00,Academic Pricing - Conference Only: USD 1099.00 URLs: Tickets: https://go.evvnt.com/791703-2?pid=5569 Brochure: https://go.evvnt.com/791703-3?pid=5569 Speakers: Wai Wong, Leonide Saad, Sobha Sivaprasad, Michael Silber, Arun Upadhyay, Allen Ho, Ashwath Jayagopal, Baruch Kuppermann, Brian Culley, Chad Bigelow, Christine Curcio, Claire Mitchell, Clark Tedford, Cyndy Grosskreutz, Dhaval Desai, Eddy Anglade, Goldis Malek, Grant Blouse, Jane Hughes, Jane Lebkowski, Jeffrey Heier, Janet Sunness, John Ash, Josh Dunaief, Justis Ehlers, Karsten Schmidt, Lloyd Diamond, Lukas Scheibler, Matt Feinsod, Michael Engles, Michael McCaleb, Nadia Waheed, Paul Ashton, Pete Coffey, Peter Kaiser, Phillip Lai, Pravin Dugel, Reenie McCarthy, Sam Barone, Sergio Leal, Shelley Boyd, SriniVas Sadda, Ted Yednock, Timothy King, Vicken Karageozian, Victor Chong, Viral Kansara